152 related articles for article (PubMed ID: 24955047)
21. Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol Guidelines.
Virani SS; Akeroyd JM; Smith SC; Al-Mallah M; Maddox TM; Morris PB; Petersen LA; Ballantyne CM; Grundy SM; Stone NJ
J Am Coll Cardiol; 2019 Aug; 74(5):712-714. PubMed ID: 31370962
[No Abstract] [Full Text] [Related]
22. [New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology].
Klose G; Beil FU; Dieplinger H; von Eckardstein A; Föger B; Gouni-Berthold I; Koenig W; Kostner GM; Landmesser U; Laufs U; Leistikow F; März W; Merkel M; Müller-Wieland D; Noll G; Parhofer KG; Paulweber B; Riesen W; Schaefer JR; Steinhagen-Thiessen E; Steinmetz A; Toplak H; Wanner C; Windler E
Internist (Berl); 2014 May; 55(5):601-6. PubMed ID: 24770979
[TBL] [Abstract][Full Text] [Related]
23. Adherence to Blood Cholesterol Treatment Guidelines Among Physicians Managing Patients With Atherosclerotic Cardiovascular Disease.
Ramsaran E; Preusse P; Sundaresan D; DiMario S; Patel J; Harrison D; Munsell M; Menzin J
Am J Cardiol; 2019 Jul; 124(2):169-175. PubMed ID: 31104775
[TBL] [Abstract][Full Text] [Related]
24. 2013 ACC/AHA Guideline: a guideline for the population - without evidence from the population.
Myerson M; Rosenson RS
Cardiovasc Drugs Ther; 2014 Jun; 28(3):203-4. PubMed ID: 24610170
[No Abstract] [Full Text] [Related]
25. Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol.
Chuzi S; Pfenniger A; Lloyd-Jones DM; Blumenthal RS; Smith SC; Virani SS; Grundy SM; Stone NJ
JAMA Cardiol; 2019 May; 4(5):473-477. PubMed ID: 30969319
[TBL] [Abstract][Full Text] [Related]
26. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
[TBL] [Abstract][Full Text] [Related]
27. Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Wilson PWF; Polonsky TS; Miedema MD; Khera A; Kosinski AS; Kuvin JT
Circulation; 2019 Jun; 139(25):e1144-e1161. PubMed ID: 30586775
[TBL] [Abstract][Full Text] [Related]
28. Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation.
Evans M; Rumberger JA; Azumano I; Napolitano JJ; Citrolo D; Kamiya T
Vasc Health Risk Manag; 2014; 10():89-100. PubMed ID: 24600231
[TBL] [Abstract][Full Text] [Related]
29. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
[TBL] [Abstract][Full Text] [Related]
30. Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk.
Agabiti Rosei E; Salvetti M
High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):217-30. PubMed ID: 27567901
[TBL] [Abstract][Full Text] [Related]
31. Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Wilson PWF; Polonsky TS; Miedema MD; Khera A; Kosinski AS; Kuvin JT
J Am Coll Cardiol; 2019 Jun; 73(24):3210-3227. PubMed ID: 30423394
[TBL] [Abstract][Full Text] [Related]
32. Merits and potential downsides of the 2013 ACC/AHA cholesterol management guidelines.
Gotto AM; Moon JE
Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):573-6. PubMed ID: 24819819
[TBL] [Abstract][Full Text] [Related]
33. 2013 ACC/AHA guideline on the treatment of blood cholesterol: a fresh interpretation of old evidence.
Psaty BM; Weiss NS
JAMA; 2014 Feb; 311(5):461-2. PubMed ID: 24264722
[No Abstract] [Full Text] [Related]
34. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide.
Pokharel Y; Tang F; Jones PG; Nambi V; Bittner VA; Hira RS; Nasir K; Chan PS; Maddox TM; Oetgen WJ; Heidenreich PA; Borden WB; Spertus JA; Petersen LA; Ballantyne CM; Virani SS
JAMA Cardiol; 2017 Apr; 2(4):361-369. PubMed ID: 28249067
[TBL] [Abstract][Full Text] [Related]
35. Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council.
Hegele RA; Gidding SS; Ginsberg HN; McPherson R; Raal FJ; Rader DJ; Robinson JG; Welty FK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2269-80. PubMed ID: 26376908
[TBL] [Abstract][Full Text] [Related]
36. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
[TBL] [Abstract][Full Text] [Related]
37. Annual influenza immunization: as important as control of blood pressure and cholesterol as secondary prevention for cardiovascular disease.
Grajewski J; Slusar M; Hayney MS
J Am Pharm Assoc (2003); 2007; 47(5):662-3. PubMed ID: 17848356
[No Abstract] [Full Text] [Related]
38. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Stone NJ; Robinson JG; Lichtenstein AH; Bairey Merz CN; Blum CB; Eckel RH; Goldberg AC; Gordon D; Levy D; Lloyd-Jones DM; McBride P; Schwartz JS; Shero ST; Smith SC; Watson K; Wilson PW;
J Am Coll Cardiol; 2014 Jul; 63(25 Pt B):2889-934. PubMed ID: 24239923
[No Abstract] [Full Text] [Related]
39. Hypercholesterolemia in youth: opportunities and obstacles to prevent premature atherosclerotic cardiovascular disease.
McNeal CJ; Dajani T; Wilson D; Cassidy-Bushrow AE; Dickerson JB; Ory M
Curr Atheroscler Rep; 2010 Jan; 12(1):20-8. PubMed ID: 20425267
[TBL] [Abstract][Full Text] [Related]
40. Case-based educational intervention to assess change in providers' knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline.
Pokharel Y; Steinberg L; Chan W; Akeroyd JM; Jones PH; Nambi V; Nasir K; Petersen L; Ballantyne CM; Virani SS
Atherosclerosis; 2016 Mar; 246():115-20. PubMed ID: 26773472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
